India's small-cap stocks experienced their strongest monthly rally in at least a decade during April, recovering significantly after a shar...

Indian stock markets saw a strong upward trend on Wednesday. The Nifty 50 and Sensex both closed higher, driven by gains in auto, FMCG, and...

Despite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...

The Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...

Domestic markets extended gains with Nifty closing above 24,000, led by banking, auto, and consumer stocks. Easing volatility and bullish t...

Despite a Rs 10 lakh crore market wipeout triggered by the Iran conflict, nearly 50 stocks showed resilience. Select gainers—including ACME...

Smallcap stocks are showing signs of a comeback after a dull 2025, driven by attractive valuations and improving earnings. The India-US tra...

Indian markets rebounded to end a five-day losing streak as trade optimism with the US lifted sentiment. Sensex and Nifty closed higher, su...

Mutual funds reduced cash reserves slightly in September. Key banks like Kotak and ICICI saw additions. Investors bought into HDFC Bank and...

Jefferies expects India’s CRDMO sector to see strong growth over 3–5 years, recommending Divi’s Labs, Cohance Lifesciences, Sai Life Scienc...

Cohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing stro...

When the Nifty and Sensex are rising every other day in tandem with bullish headlines, it is difficult to think rationally about valuations...

The Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...

ADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...

Post the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...

Market capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...

Promoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...